-

CMP Scientific Launches BioSummit™ CVA System, the Next-Generation cIEF-MS Platform for Charge Variant Analysis

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in capillary electrophoresis-mass spectrometry (CE-MS) technologies, is proud to announce the launch of its highly anticipated BioSummit™ CVA system at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. This state-of-the-art technology is set to revolutionize online charge variant analysis of recombinant protein therapeutics, offering unparalleled precision and robustness for capillary zone electrophoresis-mass spectrometry (CZE-MS) and capillary isoelectric focusing-mass spectrometry (cIEF-MS) applications.

The BioSummit™ CVA platform combines CMP’s cutting-edge EMASS-II CE-MS coupling technology, the CR3520 cIEF-MS chemistry, and a novel time-of-flight mass spectrometry system. With its high-resolution capabilities, the BioSummit™ CVA system meets the rigorous demands of modern laboratories.

Revolutionizing Charge Variant Analysis

Charge variant analysis is critical in biopharmaceutical development, enabling detailed characterization of protein therapeutics. CMP Scientific's BioSummit™ CVA system addresses the industry's need for accurate, sensitive, and reproducible charge variant analysis. By leveraging the unique advantages of CZE-MS and cIEF-MS, this new instrument offers:

  • Unmatched Precision and Sensitivity: High-resolution separation and identification of protein charge variants.
  • Streamlined Workflow: Seamless integration with CMP’s CR3520 cIEF-MS workflow, featuring an efficient reagent kit.
  • Enhanced Robustness: Advanced design ensures consistent performance with minimal maintenance requirements.
  • Comprehensive Data Analysis: Proprietary software enhances productivity with powerful tools and user-friendly interface.

A Commitment to Excellence

"The launch of our BioSummit™ CVA system marks a significant milestone in CMP Scientific's journey to advance analytical science," said Dr. James Xia, CEO of CMP Scientific. "Our team has developed a technology that meets and exceeds modern laboratory expectations. We envision that the BioSummit™ CVA system will become an indispensable tool for researchers and scientists worldwide."

CMP Scientific's CE-MS instrumentation has garnered recognition from analytical experts and industry leaders. The BioSummit™ CVA system is the latest addition to CMP’s portfolio of advanced analytical tools.

For CMP’s complete product line, please visit https://www.cmpscientific.com/products-and-services

About CMP Scientific

CMP Scientific specializes in capillary electrophoresis coupled with electrospray mass spectrometry (CE-MS) products and technologies. The company's product portfolio includes CE-MS systems, CE-MS ion sources, CE instruments, separation capillaries, electrospray emitters, cIEF-MS reagent kits, and peripheral equipment. CMP Scientific's globally patented EMASS-II CE-MS coupling technology is recognized for its stability and sensitivity.

For more information, please visit www.cmpscientific.com.

Contacts

Joshua Wiley, PhD
Director of R&D
CMP Scientific Corp
+1 530-387-4198
Joshua.wiley@cmpscientific.com

CMP Scientific


Release Versions

Contacts

Joshua Wiley, PhD
Director of R&D
CMP Scientific Corp
+1 530-387-4198
Joshua.wiley@cmpscientific.com

More News From CMP Scientific

CMP Scientific Announces Dr. Darlene Solomon to Advise on Strategy and Technology

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in capillary electrophoresis–mass spectrometry (CE-MS) technology, today announced the appointment of Dr. Darlene Solomon, former Chief Technology Officer and Senior Vice President of Agilent Technologies, and member of the National Academy of Engineering as external Executive Advisor of Strategy and Technology. “We are honored to welcome Dr. Solomon to CMP Scientific,” said James Xia, CEO of CMP Scientific. “Her deep expertise in techno...

CMP Scientific's Cutting-Edge Technology Solves CE-SDS Peak Identification Challenge

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific Corp., a leading innovator in advancing biotech analysis, has unveiled a groundbreaking method that addresses a longstanding challenge in the biotechnology industry: the accurate identification of CE-SDS peaks, essential for assessing the purity and quality of antibody therapeutics. By integrating the power of capillary zone electrophoresis-mass spectrometry (CZE-MS) with CE-SDS assays, CMP Scientific has set a new benchmark for precision, speed,...

CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis–Mass Spectrometry Solutions

BROOKLYN, N.Y.--(BUSINESS WIRE)--CMP Scientific, a leader in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies, signed a global co-marketing agreement with Agilent....
Back to Newsroom